Michael Albeck

Michael Albeck
Born October 1934
Citizenship Israeli
Fields Chemistry, Biochemistry
Institutions Bar Ilan University
Alma mater The Hebrew University of Jerusalem
Doctoral advisor Saul Patai
Known for chemistry of tellurium compounds, development of biologically-active tellurium compounds, clinical trials of the tellurium compounds AS101 and SAS

Michael Albeck (Hebrew: מיכאל אלבק) (born October 1934) is an organic and bioorganic chemist of tellurium compounds.

Biography

Michael Albeck was born in Berlin, Germany to Hanoch and Henya Albeck in October 1934. His family immigrated to Israel (then Mandatory Palestine) in 1935 and settled in Jerusalem. He earned both MSc in Chemistry (1959) and PhD (1962) from The Hebrew University of Jerusalem. He worked as Principal Investigator in the Institute for Fiber and Forest Products in Jerusalem in 1962-1964, as the head of the chemical laboratories of Mekorot Water Company in 1964-1965, and then he joined Bar Ilan University[1] as a faculty member at the Department of Chemistry, becoming a Full Professor in 1978. Prof. Albeck served as the Dean of The Faculty of Natural Sciences[2] of Bar Ilan University twice (1967-1969 and 1972-1975), as a member of the Board of Governors and the Board of Trustees of the university[3] (1982-1999) and as the university’s Rector (1982-1986) and President[4] (1986-1989). Since 2003 he is a Professor Emeritus at Bar Ilan. Prof. Albeck assumed many scientific duties outside Bar Ilan University, including member of the boards of The Weizmann Scientific Press, Dead Sea Works, The German-Israel Binational Foundation (GIF),[5] Teva Pharmaceuticals, and as the President of The Israel Chemical Society.[6] Prof. Michael Albeck is the son of the late Prof. Hanoch Albeck, who was a Professor of Talmud at the Hebrew University of Jerusalem and one of the foremost scholars of Judaic studies. Michael and his wife Shulamit, a retired Faculty member of the School of Social Work at Bar Ilan University, have four children, grandchildren and great grandchildren.

Scientific Interests and Publications

Prof. Albeck’s main scientific interests are in the chemistry [7] and biological activity [8] of organic and inorganic tellurium compounds. Two of these compounds, AS101 and SAS, exhibit immuno-modulating, antiviral and anticancer activity. They are now in various clinical trials. He published over 120 scientific publications and patents.

References

  1. ↑ Department of Chemistry, Bar Ilan University
  2. ↑ Faculty of Exact Sciences, BIU
  3. ↑ Bar Ilan Board of Trustees
  4. ↑ Bar-Ilan Presidents
  5. ↑ The German-Israeli Foundation for Scientific Research and Development (GIF)
  6. ↑ Former ICS presidents
  7. ↑ Synthesis 1989, 8, 635,DOI:10.1055/s-1989-27344; Inorg. Chem. 1998, 37, 1704,DOI:10.1021/ic971456t; ChemMedChem 2007, 2, 1601,DOI:10.1002/cmdc.200700155.
  8. ↑ Nature 1987, 330, 173,DOI:10.1038/330173a0; Nat. Immun. Cell Growth Regul. 1990, 9, 182; Cancer Res. 1991, 51, 1499, available at http://cancerres.aacrjournals.org/content/51/5/1499.full.pdf+html; Nat. Immunol. 1993, 12, 50; J. Neurochem. 2003, 85, 90; Virus Res. 2012, 166, 68,DOI:10.1016/j.virusres.2012.03.004; Cancer Res. 2014, 74, 3092,DOI:10.1158/0008-5472.CAN-13-2159.
This article is issued from Wikipedia - version of the Tuesday, February 16, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.